The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, P.
Right arrow Articles by David, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, P.
Right arrow Articles by David, C. S.

The Journal of Immunology, Vol 146, Issue 3 854-859, Copyright © 1991 by American Association of Immunologists

ARTICLES

Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA- DQ beta+ single transgenic mice

P Zhou, GD Anderson, S Savarirayan, H Inoko and CS David
Department of Immunology, Mayo Clinic, Rochester, MN 55905.

DQw6b transgenic mice have been generated by microinjecting a linearized cosmid clone containing 34-kb DQb genomic DNA, isolated from HLA-homozygous B cell line AKIBA (DR2, Dw12, DQw6), into embryos of (CBA x B10.M)F2 or (SWR x SJL)F2. Among 85 mice screened, eight mice were transgene-positive. The transgene in seven of eight founders was germline-transmitted. FACS analysis and immunohistochemical studies with DQ beta-specific mAb demonstrated that DQ beta molecules in association with mouse A alpha f molecules are expressed on peripheral mononuclear cells, spleen cells, and in thymic medulla. More interestingly, V beta 11-, V beta 5.1-, and V beta 5.2-bearing T cells, but not V beta 8.2-bearing T cells, were clonally deleted in the H-2E- negative but DQ beta+ progeny of two selected founders (260-23 and 258- 10). The deletion was found to take place intrathymically during the transition stage from immature to mature thymocyte development. We postulate that although human DQ genes are more homologous to mouse H- 2A genes, A alpha f/DQ beta hybrid molecules may possess the same self- peptide- (or superantigen)-presenting epitope as E alpha/E beta molecules critical for deletion of V beta 11-, V beta 5.1-, and V beta 5.2-bearing T cells in thymus. Our results also confirm the previous findings that accessory molecules on thymocytes such as CD4 may be involved in thymic selection, and further suggest that an interaction of mousE CD4 and mouse A alpha chain is required for the clonal deletion.


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
F. C. Hall, A. P. Cope, S. D. Patel, and G. Sonderstrup
Isolating the molecular suspect: HLA transgenic mice in the study of human autoimmune disease
Rheumatology, August 1, 1999; 38(8): 697 - 704.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Pan, T. Trejo, J. Hansen, M. Smart, and C. S. David
HLA-DR4 (DRB1*0401) Transgenic Mice Expressing an Altered CD4-Binding Site: Specificity and Magnitude of DR4-Restricted T Cell Response
J. Immunol., September 15, 1998; 161(6): 2925 - 2929.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.